# Top 50 Biotech Startup Investors in Australia in October 2023

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 21
- Stages: Series A, Seed
- Focus: Biotechnology, Manufacturing, Health Care

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Brandon Capital Partners
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 15
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 11
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Stoic VC
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Biotechnology, Medical, Health Care

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

## OneVentures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 6
- Stages: Series A, Debt Financing
- Focus: Software, Health Care, Information Technology

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 5
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 5
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Manufacturing

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## Main Sequence Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Information Technology

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

## Clean Energy Finance Corporation
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 3
- Stages: Series B, Series A, Seed
- Focus: Energy, Solar, Renewable Energy

The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Yuuwa Capital
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 3
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Analytics, Health Care

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Information Technology

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Angel
- Focus: Software, SaaS, Apps

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## Global Health Investment Fund (GHIF)
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical Device

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

## Brisbane Angels
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Seed, Angel
- Focus: Software, Information Technology, Artificial Intelligence

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

## Lowercarbon Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Biotechnology, Renewable Energy, Energy

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

## South Australian Venture Capital Fund
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, SaaS

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

## Allan Moss
- Type: Angel
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Health Care, Medical Device, Biotechnology

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

## Vectr
- Type: VC Fund
- Location: Sheung Wan, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: FinTech, Artificial Intelligence, Financial Services

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

## BridgeLane Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Software, Financial Services, Health Care

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

## Folklore Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Apps, Information Technology

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

## Grok Ventures
- Type: VC Fund
- Location: Surry Hills, New South Wales, Australia
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Renewable Energy, Software, Internet of Things

Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.

## Possible Ventures
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Information Technology, Biotechnology

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

## HealthCare Ventures
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

## Mercia Fund Managers
- Type: VC Fund
- Location: Henley In Arden, Warwickshire, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Science/Engineering

Mercia Asset Management providing equity and debt to regional businesses with growth ambition. We are your capital partners from scale-up to exit.

## Southern Cross Venture Partners
- Type: VC Fund
- Location: North Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Software, Manufacturing, Renewable Energy

Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.

## CP Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Artificial Intelligence, Machine Learning

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

## Agronomics
- Type: VC Fund
- Location: Douglas, South Lanarkshire, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Food and Beverage, Food Processing

Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.

## Grand Challenges Canada
- Type: VC Fund
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Grant, Seed, Debt Financing
- Focus: Health Care, Medical Device, Biotechnology

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

## Ellerston Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Information Technology, E-Commerce

Ellerston Capital is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.

## Northpond Ventures
- Type: VC Fund
- Location: Bethesda, Maryland, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Science/Engineering, Biotechnology, Health Care

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

## Playford Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

## Acre Venture Partners
- Type: VC Fund
- Location: Santa Monica, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Food/Beverage, Gaming, Science/Engineering

Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform business across the food value chain, with a particular focus on the agriculture, food tech and consumerverticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, IT, Data and Analytics

Right Click Capital - Australian Venture Capital Firm

## HESTA
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Sensor, Medical, Aerospace

HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.

## AbbVie Biotech Ventures
- Type: VC Fund
- Location: North Chicago, Illinois, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Science/Engineering, Health Care

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

## Alloy Ventures
- Type: VC Fund
- Location: Palo Alto, California, United States
- Relevant deals: 1
- Stages: Series C, Series B, Series D
- Focus: Software, Science/Engineering, Hardware

Alloy Ventures is an early stage venture capital firm that invests in the areas of life sciences, information technology, and cleantech.

## Terra Rossa Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

## Nanyang Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Biotechnology, Science/Engineering

Nanyang Ventures invests with the aim of building listable companies. Company spokesman John Mulquiney said the Genetic Solutions management team had been successful at commercialising the company's technology.

## CaraMed Capital
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed
- Focus: Biotechnology

CaraMed Capital is a deep-health tech venture capital fund.

## Powerhouse Ventures
- Type: VC Fund
- Location: Oakland, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Energy, Solar

Powerhouse Ventures
backs entrepreneurs building the digital infrastructure for rapid decarbonization.

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Financial, IT

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## Alta Partners
- Relevant deals: 1
- Stages: Series C, Series B
- Focus: Biotechnology, Health Care, Science/Engineering

Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.

## Accelerating Commercialisation - AusIndustry
- Type: VC Fund
- Location: Canberra, Australian Capital Territory, Australia
- Relevant deals: 1
- Stages: Grant, Pre-Seed
- Focus: Software, Mining, Hardware

A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda

## GBS Ventures
- Relevant deals: 1
- Stages: Series A, Series C, Series B
- Focus: Health Care, Biotechnology, Science/Engineering

Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnologyproduct development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics.GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.

## Closed Loop Partners
- Type: VC Fund
- Location: New City, New York, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Recycling, Supply Chain Management, Artificial Intelligence

We Invest in the Circular Economy, a New Economic Model Focused on a Profitable and Sustainable Future.

## Catherine Lacavera
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Medical, Health Care, Biotechnology

Catherine Lacavera is the VP, Legal at Google.

## Daniel Petre
- Type: Angel
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Software, Banking

Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.

## Dexcom Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 1
- Focus: Sensor, Medical, Wearables

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

## Maropost Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series A, Secondary Market
- Focus: Science/Engineering, Commerce/Shopping, Data and Analytics

Maropost Ventures is a leading private equity firm that invests in people and their companies from the earliest days through all stages of Growth. SpaceX, Compono, Pressa and Lyres make up some of their first investments.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co